Amity University confers honorary doctorate on Thumbay Moideen

coastaldigest.com news network
November 21, 2017

Dubai, Nov 21: Thumbay Moideen, the Founder President of Dubai-based global conglomerate Thumbay Group, was conferred an Honorary Doctorate at the annual convocation ceremony of Amity University – Dubai, on November 20. Mr. Moideen, the Guest of Honour of the convocation ceremony, was awarded the doctorate in the presence of distinguished dignitaries, academicians, students, teachers and parents.

An official statement by Amity University Dubai said that Mr.ThumbayMoideen was being conferred the honor in view of his “significant contributions towards promotion of medical education, trade and industry, and social and economic development of the nation.”

In his acceptance speech, Mr. Thumbay Moideen expressed his gratitude to Amity University Dubai for awardingthe doctorate. “Throughout my career, I have had the privilege of transforming lives through education and healthcare, strengthening communities and contributing to the growth and progress of the nation. I owe my success to God Almighty, the support of the government, and my team. This recognition will inspire me to do more in driving positive change,” he said.

Mr. Thumbay Moideen awarded certificates to the graduates and the honors for batch toppers.

About Mr. Thumbay Moideen

Mr. ThumbayMoideen is the Founder President of Thumbay Group, a diversified international conglomerate headquartered at DIFC - Dubai, United Arab Emirates (UAE). Starting with the establishment of Thumbay Group in 1998, he has set up business operations in 20 sectors. Today, the Group has activities in Education, Healthcare, Medical Research, Diagnostics, Retail Pharmacy, Health Communications, Retail Optical, Wellness, Nutrition Stores, Hospitality, Real Estate, Publishing, Technology, Media, Events, Medical Tourism, Trading and Marketing & Distribution.

Thumbay Group today employs close to 5000 people, which is projected to increase to around 25000 by the year 2022, with the completion of ongoing and upcoming projects. The Thumbay chain of hospitals, the constituent teaching hospitals of the Gulf Medical University are one of the largest healthcare services providers in the UAE, serving patients from over 175 nationalities. The Gulf Medical University (GMU) which is one of the leading private medical universities in the Middle East region, attracts a student cohort of 80 nationalities and faculty and staff from over 25 countries. Currently, Thumbay Group is focusing on its strategic long-term plans which will see the group scale its businesses almost ten times and expand its operations globally.

The Group plans to build three more international campuses in the next five years. This is in addition to the plans to expand the chain of academic hospitals to 15 worldwide by 2022, with a total capacity of 1000 beds in the UAE, 1500 beds in India and 750 beds elsewhere in the Gulf and in Africa. The group also plans to expand specialized retail outlets.

Comments

ABDUL SALAM BELMA
 - 
Wednesday, 22 Nov 2017

All the best, congrats to well deserved person

Ahmed Bava
 - 
Tuesday, 21 Nov 2017

Masha Allah Mabrook Mr.Moideen Thumbay

AR Shetty
 - 
Tuesday, 21 Nov 2017

Hearty Congratulations saab

Muhammed Ali Uchil
 - 
Tuesday, 21 Nov 2017

Great honor-A Doctorate from World reputed Amity University-

thanks for  choosing the  right and most deserved person for 

this Privilege .

 

Heartily Congratulations Moideen Saab.

Danish
 - 
Tuesday, 21 Nov 2017

Wow. great! All the best for your future ventures..

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 22,2020

Mangaluru, Apr 22: A staff working at the office of Dakshina Kannada Deputy Commissioner was sent to quarantine as a precautionary measure here in the city on Wednesday.

The staff reportedly is a distant relative of a woman (native of Bantwal) who recently died due to killer Corona Virus in Wenlock Hospital, prompting the DC office to send the staff for 14-day quarantine.

According to the reports the staff had met the Doctor who was treating the woman and had inquired about her health condition on April 18.

However the staff did not meet the woman when she was in hospital as she was being treated in the ICU.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 13,2020

Mangaluru, Jan 13: A truck parked at the site of protest against the new citizenship law and National Register of Citizens (NRC) at Deralakatte on the outskirts of the city was charred down to ashes after it was set on fire by miscreants, police said here on Monday.

Police said that Deralakatte Citizenship Protection Committee had organised a protest rally against the Citizenship Amendment Act (CAA) here on Sunday. After the rally concluded, a few unidentified miscreants set the vehicle on fire.

The incident resulted in chaos, causing panic among the locals who informed the police immediately.

Condemning the incident, the local unit of Popular Front of India has claimed that the incident was an attempt by saffronist goons to disrupt peace and trigger communal riot in the region. It has urged the police to nab the accused immediately without yielding to any political pressure.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 28,2020

Bengaluru, Mar 28: Sun Tsu, in 'The Art of War' speaks of a skilful general who can subdue his enemy without any fighting. This constitutes the ultimate triumph which is referred to as stratagem. Today, we would need one such when we are faced with the '21-day corona challenge' for India.
Nearly four weeks back, Dr Jyothsna Rao, Dr Gururaj Rao and I sat across the OPD in the afternoon at HCG Bengaluru discussing our ongoing cancer immunology research. While on this topic, we drifted into the discussion on the coronavirus. During this engaging discussion, we wondered the similarity of the enigma between the virus and cancer. I paused to ask Dr Jyothsna and Dr Guru - how we wish we could do something against this virus.
Dr Jyothsna is a PhD from NCBS and had worked under Dr Ralph Steinman, physician and researcher from Rockefeller University, who won the Nobel Prize for his discovery of the dendritic cell and its role in adaptive immunity in 2011. Dr Gururaj is a molecular and cell biologist who did his PhD at the Chapel Hill, University of North Carolina and is the Director of iCrest.
Jyothsna while hearing our perplexing conversation on the covid intervened, "Yes, surely. I think we should take a break from cancer and focus on the innate and adaptive immunity role in COVID-19."
Thus began this sincere attempt to relook the human immune system from the eyes of the COVID-19.
We have 10 types of immune cells at the least which are widely dispersed in millions across the body. When our body is invaded by a foreign organism (bacteria, fungi or virus), these cells work with each other to destroy the invader.
Now, the question is - how do the immune cells talk to each other? They use small-molecule substances called cytokines (cyto means cells; kine means movement). There are many cytokines that are involved in work on the immune system. The most relevant for viruses are interferons.
Interferons (IFN) as the name reflects have an ability to interfere with the viral activity and stop their multiplication. These specialised signal proteins are released by our cells in response to a viral attack to forewarn other cells. They help build the antiviral proteins within the cells to kill the virus as it tries to invade the new cells.
Historically, interferons are a group of cytokines known to be potent antiviral agents against viruses and a hallmark cytokine induced by the host upon viral infections. Interferons possess unique immunoregulatory activities and are signature cytokines released by (TH1) T immune cells, which are crucial in viral infections.
As the outbreak of COVID-19 grapples us, an urgent need for finding strategies to combat the virus is growing. Coronaviruses (CoVs) are a group of RNA viruses. In patients infected with coronavirus, it was indicated that the activation of the IFN does not occur until 48 hours post-infection. Thus the delayed IFN-related antiviral response by the healthy cells leads to coronavirus evade the immune response.
Numerous studies have presented the success in defeating CoVs by the direct administration of IFNs. In a combination as a concoction, it was shown to synergistically inhibit the virus replication in vitro.
Moreover, it is understood that the earlier induction of IFNs in children although they have a less developed immune system could be the reason behind the children being least affected.
The key to success in reducing the disease fatality might be the stimulation of the immune responses to trigger IFN production at the very early stages of the disease, which might be done through the administration of IFN. Despite the evidence for the efficacy of IFNs in treating CoV-induced infections, the proper dosing and ideal timing for such interventions needs to be verified in clinical trials.
For the later stages of the diseases in advance stages where patients are on ventilator and have developed respiratory distress, we propose to utilise the mesenchymal cells derived from donor bone marrow that have been known to treat acute respiratory syndrome. Mesenchymal cells are known to possess anti-inflammatory activity and thus used often in autoimmune diseases.
With this scientific background, we have activated T cells from healthy donors, in a cGMP facility at iCrest - HCG hospital with an enriched cocktail of cytokines rich in Interferons. Injections of this cocktail we believe will result in a surge of cytokines in the body of the infected person and will boost his ability to fight the virus in the early phases. We are in the initial phases of this study and hope to be ready in the coming weeks with meaningful data on its potential utility.
Currently, it awaits government approvals (Union and state) and we have applied to central drugs authority for their initial evaluation and further directions.
As my Guru often expounded the philosophy of 'Seva' - the goal of education is knowledge, the end goal of knowledge is service. In this attempt to serve our fellow humans at this brink of unprecedented crisis, medical fraternity stands with you and promises to do our best for your safety.
We assure to exhaust every bit of our spirit in this fight against coronavirus. We have lost the sight of shores and travelled thus far, but that is the mandatory first step to cross the ocean. Are we going to succeed in this battle, is something only time will answer. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.